Low back pain

Low back pain

Mainstay Medical has recently secured $125 million in funding to support the expansion of its neuromodulation device, which has received an updated FDA clearance. This device aims to provide relief for individuals suffering from chronic low back pain, offering a non-invasive treatment option for those in need.

With the rising prevalence of low back pain globally, innovative solutions such as Mainstay Medical's neuromodulation implant are crucial in improving the quality of life for patients. By addressing the root cause of the pain and providing targeted relief, this technology has the potential to revolutionize the way we approach and manage chronic back pain.